Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease | Zendy

Moo Yong Park | Zendy; Sandra M. Herrmann | Zendy; Ahmed Saad | Zendy; Alfonso Eirin | Zendy; Hui Tang | Zendy; Amir Lerman | Zendy; Stephen C. Textor | Zendy; Lilach O. Lerman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease

Author(s) -

Moo Yong Park,

Sandra M. Herrmann,

Ahmed Saad,

Alfonso Eirin,

Hui Tang,

Amir Lerman,

Stephen C. Textor,

Lilach O. Lerman

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07290714

Subject(s) - medicine , klotho , renovascular hypertension , supar , plasminogen activator , kidney , renal function , endocrinology , plasminogen activator inhibitor 1 , basic fibroblast growth factor , renal vein , cardiology , urokinase receptor , gastroenterology , receptor , growth factor

Occlusive renovascular disease and hypertension may progress to CKD. Circulating levels of several biomarkers, including fibroblast growth factor (FGF)-23, Klotho, and soluble urokinase plasminogen activator receptor (suPAR), are altered in patients with CKD, but their role in essential hypertension (EH) and renovascular hypertension (RVH) remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research